JPMorgan Maintains Underweight Rating on Fresenius Medical Care
JPMorgan Chase & Co. has maintained its 'Underweight' rating on Fresenius Medical Care, citing concerns over consensus estimates and potential headwinds from US reimbursement costs.
Stocks · News reference
Fresenius Medical Care Announces Share Buyback Progress
Fresenius Medical Care AG reported the acquisition of 111,000 shares as part of its ongoing share buyback program.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Shares of dialysis services and equipment companies are trading lower after reports suggesting that the Trump administration is preparing a new kidney care plan that stresses market competition and preventative care, which may contain risk for current business models.
'HHS releases new kidney care plan' - Axios Exclusive
https://www.axios.com/2026/10/20/kidney-care-plan-kennedy